Rpg Life Sciences Ltd. Share Price & Stock Analysis

Rpg Life Sciences Ltd. (NSE: RPGLIFE, BSE: 532983) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹4,310 Cr, it ranks #902 by market cap among the 6,197 Indian listed companies on FinBizNet, and #30 of 86 in Medicinal Chemicals and Botanical Products. At ₹2,569.00 (as of 16 Nov 2026), the share price is 17.9% below its 52-week high of ₹3,127.80 and 48.2% above its 52-week low of ₹1,733.00. The share price is up 6.3% over one year and down 9.9% over three months.

Key Metrics

Current Price₹2,569.00
Market Cap₹4,310 Cr
NSE SymbolRPGLIFE
BSE Code532983
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio37.5
Return on Equity20.28%
Return on Assets10.84%
52-Week Range₹1,733.00 – ₹3,127.80
1-Year Price Change+6.3%
3-Month Price Change-9.9%
Beta (1Y)0.06
Dividend Yield0.92%
HeadquartersMumbai, Maharashtra
Websitewww.rpglifesciences.com

Latest Quarterly Results — Q2 FY27

Revenue₹212 Cr
Net Profit₹28 Cr
Net Margin13.3%
EPS (Basic)₹17.07
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Rpg Life Sciences Ltd. Quarterly Revenue and Profit Trend

Rpg Life Sciences Ltd. reported revenue of ₹212 Cr in Q2 FY27, up 8.2% from ₹196 Cr in Q1 FY27. It posted a net profit of ₹28 Cr for the quarter, against a net profit of ₹31 Cr in Q1 FY27 (down 8.3%). Across the 4 quarters from Q3 FY26 to Q2 FY27, quarterly revenue ranged from ₹177 Cr (Q4 FY26) to ₹212 Cr (Q2 FY27). The company was profitable in each of these 4 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹212 Cr₹28 Cr13.3%
Q1 FY27₹196 Cr₹31 Cr15.7%
Q4 FY26₹177 Cr₹30 Cr16.9%
Q3 FY26₹180 Cr₹22 Cr12.3%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 72.95% of Rpg Life Sciences Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 40.9% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Rpg Life Sciences Ltd.

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was

Products and Services

1. Pharmaceuticals-This segment manufactures and markets branded formulations, generics, and active pharmaceutical ingredients. 2. Investment & Lending-0 3. Corporate-0

Rpg Life Sciences Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Rpg Life Sciences Ltd.₹4,310 Cr37.520.28%₹212 Cr+6.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Rpg Life Sciences Ltd.?

Rpg Life Sciences Ltd. is trading at ₹2,569.00, with a market capitalisation of ₹4,310 Cr.

Which sector does Rpg Life Sciences Ltd. belong to?

Rpg Life Sciences Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Rpg Life Sciences Ltd.?

Rpg Life Sciences Ltd. has a P/E of 37.5 and a return on equity of 20.28%.

What is the stock symbol of Rpg Life Sciences Ltd.?

Rpg Life Sciences Ltd. is listed on the NSE under the symbol RPGLIFE and on the BSE under the scrip code 532983.

How has Rpg Life Sciences Ltd.'s share price moved over the past year?

Rpg Life Sciences Ltd.'s share price is up 6.3% over one year and down 9.9% over three months. Its 52-week range is ₹1,733.00 to ₹3,127.80.

What were Rpg Life Sciences Ltd.'s latest quarterly results?

In Q2 FY27, Rpg Life Sciences Ltd. reported revenue of ₹212 Cr and net profit of ₹28 Cr, with basic EPS of ₹17.07 (consolidated, parsed from the company's exchange filing).

What is the promoter holding in Rpg Life Sciences Ltd.?

Promoters held 72.95% of Rpg Life Sciences Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.